Augmentation of wound healing by royal jelly (RJ) in streptozotocin-diabetic rats.
Chronically diabetic rats prepared by a single i.v. injection of streptozotocin were used to study whether royal jelly (RJ) possesses a hypoglycemic reaction and whether it can augment wound healing. Oral RJ administration of 10, 100 and 1000 mg/kg/day did not show any insulin-like activity (the hypoglycemic reaction). RJ, however, showed some anti-inflammatory activity by decreasing exudation and collagen formation in granulation tissue formation in the cotton pellet method. RJ also shortened the healing period of desquamated skin lesions. Thus, RJ possesses an anti-inflammatory action and is able to augment wound healing, but does not have an insulin-like action in streptozotocin-diabetic rats.
Fujii
A
A
Department of Pharmacology, Nihon University School of Dentistry, Matsudo, Japan.
Kobayashi
S
S
Kuboyama
N
N
Furukawa
Y
Y
Kaneko
Y
Y
Ishihama
S
S
Yamamoto
H
H
Tamura
T
T
D000818:Animals; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D003921:Diabetes Mellitus, Experimental / Q000473:pathology / Q000503:physiopathology*; D005227:Fatty Acids / Q000494:pharmacology*; D006097:Granulation Tissue / Q000187:drug effects; D007668:Kidney / Q000473:pathology; D008297:Male; D010179:Pancreas / Q000473:pathology; D051381:Rats; D011919:Rats, Inbred Strains; D012867:Skin / Q000187:drug effects; D014945:Wound Healing / Q000187:drug effects*; D000099219:Royal Jelly
D001786:Blood Glucose; D005227:Fatty Acids; D000099219:Royal Jelly